Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products.
Lincoln Pharmaceuticals is informing shareholders about its upcoming Annual General Meeting and the availability of its Annual Report for FY25-26 via a web-link on their website. This communication is specifically for those who haven't registered their email addresses.
Lincoln Pharma has set September 11, 2026, as the Record Date for its 32nd Annual General Meeting. Shareholders holding shares by this date will be eligible for a final dividend of ₹1.80 per share (18% of face value) for FY2025-26, pending approval at the AGM on September 30, 2026. Book...